American International Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,099
Closed -$26.7K 2937
2024
Q1
$26.7K Sell
5,099
-44
-0.9% -$231 ﹤0.01% 2898
2023
Q4
$26.9K Sell
5,143
-21
-0.4% -$110 ﹤0.01% 2933
2023
Q3
$81.4K Buy
5,164
+184
+4% +$2.9K ﹤0.01% 2623
2023
Q2
$96.8K Sell
4,980
-617
-11% -$12K ﹤0.01% 2595
2023
Q1
$159K Buy
5,597
+24
+0.4% +$681 ﹤0.01% 2243
2022
Q4
$163K Sell
5,573
-127
-2% -$3.71K ﹤0.01% 2248
2022
Q3
$151K Buy
5,700
+22
+0.4% +$583 ﹤0.01% 2320
2022
Q2
$252K Sell
5,678
-868
-13% -$38.5K ﹤0.01% 2042
2022
Q1
$324K Sell
6,546
-403
-6% -$19.9K ﹤0.01% 1968
2021
Q4
$354K Sell
6,949
-335
-5% -$17.1K ﹤0.01% 2030
2021
Q3
$406K Sell
7,284
-264
-3% -$14.7K ﹤0.01% 1997
2021
Q2
$323 Buy
7,548
+533
+8% +$23 ﹤0.01% 2207
2021
Q1
$293 Sell
7,015
-89
-1% -$4 ﹤0.01% 2153
2020
Q4
$331 Sell
7,104
-535
-7% -$25 ﹤0.01% 1999
2020
Q3
$325K Buy
7,639
+2
+0% +$85 ﹤0.01% 1831
2020
Q2
$366K Buy
7,637
+1,277
+20% +$61.2K ﹤0.01% 1760
2020
Q1
$293K Sell
6,360
-312
-5% -$14.4K ﹤0.01% 1695
2019
Q4
$401K Sell
6,672
-190
-3% -$11.4K ﹤0.01% 1819
2019
Q3
$388K Sell
6,862
-212
-3% -$12K ﹤0.01% 1797
2019
Q2
$394K Sell
7,074
-878
-11% -$48.9K ﹤0.01% 1833
2019
Q1
$401K Sell
7,952
-298
-4% -$15K ﹤0.01% 1840
2018
Q4
$332K Sell
8,250
-116
-1% -$4.67K ﹤0.01% 1889
2018
Q3
$580K Buy
8,366
+594
+8% +$41.2K ﹤0.01% 1796
2018
Q2
$588K Buy
7,772
+2,633
+51% +$199K ﹤0.01% 1723
2018
Q1
$271K Sell
5,139
-1,292
-20% -$68.1K ﹤0.01% 2088
2017
Q4
$344K Sell
6,431
-131
-2% -$7.01K ﹤0.01% 2003
2017
Q3
$391K Buy
6,562
+446
+7% +$26.6K ﹤0.01% 1902
2017
Q2
$482K Buy
6,116
+665
+12% +$52.4K ﹤0.01% 1734
2017
Q1
$452K Sell
5,451
-881
-14% -$73.1K ﹤0.01% 1661
2016
Q4
$502K Sell
6,332
-104
-2% -$8.25K ﹤0.01% 1631
2016
Q3
$451K Buy
6,436
+1,339
+26% +$93.7K ﹤0.01% 1675
2016
Q2
$198K Sell
5,097
-528
-9% -$20.5K ﹤0.01% 2140
2016
Q1
$228K Hold
5,625
﹤0.01% 2664
2015
Q4
$499K Sell
5,625
-9
-0.2% -$798 ﹤0.01% 2039
2015
Q3
$417K Buy
5,634
+606
+12% +$44.9K ﹤0.01% 2169
2015
Q2
$407K Buy
+5,028
New +$407K ﹤0.01% 2358